HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vanna Micheli Selected Research

Xanthine Dehydrogenase

1/2019Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vanna Micheli Research Topics

Disease

8Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
03/2020 - 08/2002
6Hyperuricemia
03/2020 - 01/2006
3Nervous System Diseases (Neurological Disorders)
01/2019 - 01/2011
3Inborn Genetic Diseases (Disease, Hereditary)
01/2019 - 06/2009
3Renal Insufficiency (Renal Failure)
01/2019 - 10/2002
3Neuroblastoma
02/2005 - 03/2004
2Neurologic Manifestations (Neurological Manifestations)
02/2010 - 01/2006
1Cognitive Dysfunction
03/2020
1Self Mutilation
03/2020
1Joint Diseases (Joint Disease)
01/2017
1Alkaptonuria
01/2017
1Arthritis (Polyarthritis)
01/2017
1Nephrolithiasis
02/2012
1Chronic Kidney Failure (Chronic Renal Failure)
02/2012
1Acute Kidney Injury (Acute Renal Failure)
02/2012
1Peptic Ulcer (Peptic Ulcers)
11/2011
1Kidney Calculi (Kidney Stone)
11/2011
1Type II Xanthinuria
11/2011
1Arthralgia (Joint Pain)
11/2011
1Type I Xanthinuria
11/2011
1Intellectual Disability (Idiocy)
01/2011
1Peripheral Nervous System Diseases (PNS Diseases)
12/2009
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2009
1Systemic Scleroderma (Systemic Sclerosis)
07/2009
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
07/2009
1Coffin-Lowry Syndrome (Syndrome, Coffin-Lowry)
09/2007
1X-Linked Genetic Diseases
11/2006
1Gout
01/2006
1Neoplasms (Cancer)
04/2005
1Neuroectodermal Tumors (Neuroectodermal Tumor)
03/2004

Drug/Important Bio-Agent (IBA)

8Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
03/2020 - 08/2002
4purineIBA
01/2011 - 08/2002
3Uric Acid (Urate)IBA
01/2019 - 06/2009
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2005 - 03/2004
2XanthineIBA
01/2019 - 11/2011
2Nucleic AcidsIBA
12/2011 - 01/2011
2PyrimidinesIBA
12/2011 - 01/2011
2PurinesIBA
12/2011 - 01/2011
2EnzymesIBA
11/2006 - 08/2002
2Guanine NucleotidesIBA
02/2005 - 03/2004
1HypoxanthineIBA
01/2019
1Allopurinol (Remid)FDA LinkGeneric
01/2019
1immucillin GIBA
01/2019
1Xanthine DehydrogenaseIBA
01/2019
1Homogentisic AcidIBA
01/2017
1PolymersIBA
01/2017
1Sulfite OxidaseIBA
11/2011
1Aldehyde OxidaseIBA
11/2011
1pyrimidineIBA
01/2011
1Adenylosuccinate LyaseIBA
02/2010
1Phosphoribosylaminoimidazolecarboxamide FormyltransferaseIBA
02/2010
1IMP cyclohydrolaseIBA
02/2010
1Thymidine PhosphorylaseIBA
12/2009
1Messenger RNA (mRNA)IBA
08/2009
1Serotonin ReceptorsIBA
08/2009
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2009
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2007
1AngiopoietinsIBA
04/2005
1Inosine Monophosphate (IMP)IBA
02/2005
1Oxidoreductases (Dehydrogenase)IBA
02/2005
1ProdrugsIBA
03/2004
1EstersIBA
03/2004
1NucleotidesIBA
08/2002
1pyridineIBA
08/2002

Therapy/Procedure

1Therapeutics
01/2019
1Kidney Transplantation
02/2012
1Radiotherapy
04/2005